Lipidated Peptide Dendrimers Killing Multidrug-Resistant Bacteria

Area of Science:

• Medicinal Chemistry
• Biotechnology
• Microbiology

Background:

• Multidrug-resistant (MDR) bacteria pose a significant global health threat, necessitating the development of novel antimicrobial agents.
• Existing antibiotic classes are becoming less effective against critical pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus.

Purpose of the Study:

• To investigate the antibacterial efficacy of second-generation (G2) peptide dendrimers functionalized with a fatty acid chain.
• To explore the mechanism of action of these novel lipopeptide dendrimers against MDR bacteria.

Main Methods:

• Synthesis and characterization of G2 peptide dendrimers with a core fatty acid.
• In vitro antibacterial assays against Gram-negative and Gram-positive MDR bacterial strains.
• Circular dichroism and molecular dynamics simulations to elucidate the mechanism of action.
• In vivo efficacy studies using MDR bacterial isolates.

Main Results:

• The lipopeptide dendrimer TNS18 demonstrated potent bactericidal activity against MDR Gram-negative bacteria (Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli) and Gram-positive bacteria (methicillin-resistant Staphylococcus aureus).
• Structural studies suggest TNS18 undergoes conformational changes upon membrane interaction, leading to membrane disruption and bacterial cell death.
• TNS18 exhibited promising in vivo activity against MDR Acinetobacter baumannii and Escherichia coli.

Conclusions:

• Lipidated peptide dendrimers represent a novel class of antibacterial agents with broad-spectrum activity against challenging MDR pathogens.
• The unique mechanism involving membrane disruption offers a potential strategy to overcome existing resistance mechanisms.
• Further development of these compounds could lead to new therapeutic options for treating MDR bacterial infections.